Recent

% | $
Quotes you view appear here for quick access.

StemCells Inc. Message Board

  • iminjim iminjim Oct 16, 2012 11:42 AM Flag

    WEDBUSH GIVES SRPT $70 TARGET LINK

    News Breaks
    October 16, 2012
    08:34 EDT SRPT Sarepta data supports eteplirsen's efficacy, says Wedbush
    Wedbush says data presented over the weekend at the World Muscle Society provides additional support for Sarepta's eteplirsen's efficacy. The firm reiterates an Outperform rating on the stock with a $70 price target.

 
STEM
0.5321-0.0165(-3.01%)12:41 PMEDT